Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: Evidence that excision of the native heart contributes to post-transplant hypertension

Journal of the American College of Cardiology

Volumn 44, Issue 6, 2004, Pages 1254-1260

  Taegtmeyer, Anne B ^a   Crook, Angela M ^b   Barton, Paul J R ^a   Banner, Nicholas R ^a,c  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b Westminster Primary Care Trust   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATINE; CYCLOSPORIN; STEROID;

ADULT; AORTA; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART TRANSPLANTATION; HETEROTOPIC CARDIAC TRANSPLANTATION; HUMAN; HYPERTENSION; INCIDENCE; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORTHOTOPIC TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIAGNOSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ADOLESCENT; ADULT; AGED; AORTA; BLOOD PRESSURE; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SYSTOLE; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HETEROTOPIC; TREATMENT OUTCOME;

EID: 4444243527     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.06.027     Document Type: Article

References (24)

1. M.I. Hertz, D.O. Taylor, E.P Trulock The registry of the International Society for Heart and Lung Transplantation: Nineteenth Official Report2002 J Heart Lung Transplant 21 2002 950 970
2. E. Ozdogan, N. Banner, M. Fitzgerald, F. Musumeci, A. Khaghani, M. Yacoub Factors influencing the development of hypertension after heart transplantation J Heart Lung Transplant 9 1990 548 553
3. U. Scherrer, S. Vissing, B Morgan Cyclosporine-induced sympathetic activation and hypertension after heart transplantation N Engl J Med 323 1990 693 699
4. G. Parry, B. Meiser, G. Rabago The clinical impact of cyclosporine nephrotoxicity in heart transplantation Transplantation 69 2000 SS23 6
5. C. Bossaller, U. Forstermann, R. Hertel, C. Olbricht, V. Reschle, E. Fleck Cyclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production Eur J Pharmacol 165 1989 165 169
6. O. Guckelberger, W. Bechstein, R Neuhaus Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation Clin Transplant 11 1997 60 65
7. R. Morrison, H. Short, G. Noon, A. Frost Hypertension after lung transplantation J Heart Lung Transplant 12 1993 928 931
8. R. Parent, P. Stanley, C. Chartrand Long term daily study of blood volume in cardiac autotransplanted dogs Eur Surg Res 19 1988 193 199
9. R.W. Braith, R.M. Mills, C.S Wilcox Fluid homeostasis after heart transplantation: the role of cardiac denervation J Heart Lung Transplant 15 1996 872 880
10. P.K. Mohanty, M.D. Thames, J. Arrowood, J.R. Sowers, C. McNamara, S. Szentpetry Impairment of cardiopulmonary baroreflex following cardiac transplantation in humans Circulation 75 1987 914 921
11. N.R. Banner, A. Khaghani, M., et al Fitzgerald The expanding role of cardiac transplantation R. Unger Assisted Circulation III 1989 Springer-Verlag Berlin, Heidelberg 448 467
12. R.A. Bleasdale, N.R. Banner, A.C. Anyanwu, A.G. Mitchell, A. Khaghani, M.H. Yacoub Determinants of outcome after heterotopic heart transplantation J Heart Lung Transplant 21 2002 867 873
13. D.W. Cockroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
14. A.V. Chobanian, G.L. Bakris, H.R Black The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
15. E. O'Brien, B. Wateber, G. Parati, J. Staessen, G. Myers Blood pressure measuring devices: recommendations of the European Society of Hypertension BMJ 322 2001 531 536
16. M.E. Billingham, N.R. Cary, M.E Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group, The International Society for Heart Transplantation J Heart Transplant 9 1990 587 593
17. E. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
18. D.R. Cox Regression models and life-tables (with discussion) J R Stat Soc B 34 1972 187 220
19. D.O. Taylor, M.L. Barr, B Radovancevic A randomised multicenter comparison of tacrolimus and cyclosporin immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 1999 336 345
20. G. Mancia, D. Donald Demonstration that atria, ventricles and lungs each are responsible for a tonic inhibition of the vasomotor center in the dog Circ Res 36 1975 310 318
21. J.A. de Lemos, D.K. McGuire, M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
22. M.G. Buckley, M.H. Yacoub, D.R.J. Singer Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients J Hum Hypertens 12 1998 825 826
23. T. Akasaka, D. Lythall, A Cheng Continuous aortic regurgitation in severely dysfunctional native hearts after heterotopic cardiac transplantation Am J Cardiol 63 1989 1483 1488
24. R. Cowell, J. Morris-Thurgood, J Coghlan Postoperative hemodynamic improvement with paced linkage of the donor and recipient hearts following heterotopic cardiac transplantation Clin Cardiol 17 1994 542 546